The team

Department of Bacterial Resistances

The Department of Bacterial Resistances studies how interactions between the host, its microbiota and drugs (particularly anti-infective drugs, but not exclusively) influence bacterial resistance to antibiotics. We are working in particular on digestive colonisation by multi-resistant Enterobacteriaceae, and are testing the possibility of treating this colonisation with live bacteria ('probiotics') or polysaccharides ('prebiotics'). We are also working on improving the use of antibiotics, with the aim of ensuring effective treatment of bacterial infections (particularly pneumonia and community-acquired urinary tract infections) while minimising the risk of emergence, persistence and spread of multi-resistant bacteria.

Teacher-researchers

Eric BATARD

Professor - Hospital Practitioner - Head of Department

Ronan BELLOUARD

University Hospital Assistant

Gabriel BIRGAND

Praticien Hospitalier – HDR - chaire INSERM Jr.

Céline BOURIGAULT

Hospital practitioner

Eric DAILLY

Professor - Hospital Practitioner

Laure DE DECKER

Professor - Hospital Practitioner

Michel DION

Professeur Emérite

Matthieu GRÉGOIRE

Professor - Hospital Practitioner

François JAVAUDIN

Hospital practitioner - Associate Professor

Sébastien Lalanne

Hospital practitioner - Associate Researcher

Quentin LE BASTARD

University Hospital Practitioner

Brice LECLERE

Assistant Professor – Hospital Practitioner

Didier LEPELLETIER

Professor - Hospital Practitioner

Paul Le Turnier

Hospital practitioner - Associate Researcher

Marie-Anne VIBET

Engineer PhD

Technical staff

Nicolas Helsens

Engineer

Maxence MOUGON

Engineer

PhD students

Other departments


Department of Medical Mycology and Parasitology

The Department of Medical Mycology and Parasitology is supported by university and hospital-university staff, enabling it to focus on health-related issues. Research strategies benefit from expertise in cell culture, signalling, molecular biology, immunology applied to microbiology, recombinant protein production (P2R platform) and in vivo models. Its activities focus mainly on resistance issues and the discovery of new therapeutic targets.

Department of Medicinal Chemistry

The department of Medicinal Chemistry is involved in Drug Discovery, i.e. the design, synthesis, purification, structural elucidation and study of structure-activity relationships of original heterocyclic molecules as antifungal, antiparasitic and antibacterial drug candidates. The physicochemical and ADME-Tox properties of compounds of biological interest are also discussed in all the projects.